SPOTLIGHT -
New Product Newswire for November 17, 2003
FDA Approves Sotagliflozin For Heart Failure Across Full Range of LVEF
The medication is broadly approved for heart failure with preserved or reduced ejection fraction.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Two Medications for Treatment of Schizophrenia
Otsuka America Pharmaceutical and Lundbeck’s Alify Asimtufii (aripiprazole) also was approved for maintenance monotherapy treatment of bipolar I disorder in adults.
FDA Approves Qalsody, First-of-its-Kind Treatment for Rare Form of ALS
The drug treats amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).
FDA Approves Ruxolitinib Cream 1.5% to Treat Nonsegmental Vitiligo
Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.
Top Pharmacy Innovations of 2021
From medication to legislation, multiple developments have advanced the pharmacy profession this year.
